adult craniopharyngioma
Showing 1 - 25 of >10,000
Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)
Recruiting
- Adamantinomatous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
-
Aurora, Colorado
- +17 more
Jan 8, 2023
Brain and CNS Tumors, Radiation Toxicity Trial in United States (dietary supplement, drug, procedure)
Completed
- Brain and Central Nervous System Tumors
- Radiation Toxicity
- EGb761
- +2 more
-
Phoenix, Arizona
- +3 more
Sep 7, 2021
Craniopharyngioma Trial in Paris, Villejuif (Protontherapy)
Completed
- Craniopharyngioma
- Protontherapy
-
Paris, France
- +2 more
Apr 21, 2022
Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Binimetinib Oral Tablet
Not yet recruiting
- Adamantinous Craniopharyngioma
- Recurrent Adamantinomatous Craniopharyngioma
- Binimetinib Oral Tablet [Mektovi]
-
Aurora, Colorado
- +17 more
Nov 28, 2022
Brain Tumors, Metastatic Disease Trial in United States (donepezil HCl, Placebo)
Completed
- Brain Tumors
- Metastatic Disease
- donepezil hydrochloride
- Placebo
-
Wichita, Kansas
- +15 more
Sep 27, 2021
Craniopharyngioma, Obesity Trial in Oldenburg
Recruiting
- Craniopharyngioma
- Obesity
-
Oldenburg, Niedersachsen, GermanyKlinikum Oldenburg
Mar 29, 2022
Craniopharyngioma Trial in Jacksonville, Memphis (procedure, device, drug)
Active, not recruiting
- Craniopharyngioma
- Radical Surgery or Limited Surgery
- +3 more
-
Jacksonville, Florida
- +1 more
Jan 5, 2022
Craniopharyngioma With Tumoral Hemorrhage
Completed
- Craniopharyngioma
- Apoplexy
- intratumoral hemorrhage
- (no location specified)
Jun 21, 2021
Craniopharyngioma Trial in Memphis (Proton Therapy, Surgery)
Recruiting
- Craniopharyngioma
- Proton Therapy
- Surgery
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 20, 2021
Undergoing Stereotactic Radiosurgery for Brain Tumors or Other
Completed
- Brain and Central Nervous System Tumors
- +2 more
- Questionnaire
-
Cleveland, OhioCleveland Clinic Taussig Cancer Center
Jul 23, 2020
Obesity Trial in Paris La Defense
Recruiting
- Obesity
-
Paris La Defense, FrancePitié-Salpêtrière Hospital, AP-HP -Nutrition department
Oct 21, 2020
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
Not yet recruiting
- Ulcerative Colitis
- (no location specified)
Nov 20, 2023
T2DM (Type 2 Diabetes) Trial in Beijing (HSK7653, Placebo)
Completed
- T2DM (Type 2 Diabetes Mellitus)
- HSK7653
- Placebo
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Aug 1, 2023
Severity in Juvenile and Adult-onset Dermatomyositis
Not yet recruiting
- Dermatomyositis
- evaluation of clinical severity
- (no location specified)
Aug 16, 2023
Evaluation of the SickKids Team Obesity Management Program
Recruiting
- Obesity
- STOMP Clinic
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Sep 12, 2022
Suture Trial in Hong Kong (Virtual reality)
Recruiting
- Suture
- Virtual reality
-
Hong Kong, Hong KongTuen Mun Hospital-Emergency department
Mar 21, 2023
Chronic Hepatitis b Trial in Wuhan (TQA3038 injection, TQA3038 injection matching )
Not yet recruiting
- Chronic Hepatitis b
- TQA3038 injection
- TQA3038 injection matching placebo
-
Wuhan, Hubei, ChinaTongji Hospital
Oct 17, 2023
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset Trial in Japan (Anakinra, Placebo)
Recruiting
- Still's Disease, Juvenile Onset
- Still's Disease, Adult-Onset
- Anakinra
- Placebo
-
Chiba-shi, Chiba, Japan
- +17 more
Apr 3, 2023
Electronic Cigarette Use, E-Cig Use, Cigarette Smoking Trial in Los Angeles (E-cigarette e-liquid self-administration)
Completed
- Electronic Cigarette Use
- +3 more
- E-cigarette e-liquid self-administration
-
Los Angeles, CaliforniaUniversity of Southern California
Jul 14, 2023
Pulmonary Arterial Hypertension Trial (PF-07868489, Placebo for PF-07868489)
Not yet recruiting
- Pulmonary Arterial Hypertension
- PF-07868489
- Placebo for PF-07868489
- (no location specified)
Nov 14, 2023
Bleeding Disorder Trial in Charlottesville (Recombinant von Willebrand Factor)
Not yet recruiting
- Bleeding Disorder
- Recombinant von Willebrand Factor
-
Charlottesville, VirginiaUVA Hospital
Nov 3, 2023
Healthy Trial (Drug: PF-07817883)
Not yet recruiting
- Healthy
- Drug: PF-07817883
- (no location specified)
Nov 2, 2023
Alzheimer Trial in Arlington (Reminiscence with digital storytelling, Social wellness with scrapbook or journal)
Completed
- Alzheimer Disease
- Reminiscence with digital storytelling
- Social wellness with scrapbook or journal
-
Arlington, TexasThe University of Texas at Arlington
Aug 7, 2023